Sign Up to like & get
recommendations!
1
Published in 2023 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2023.2204187
Abstract: ABSTRACT Introduction Lower-sodium oxybate (LXB) is a novel formulation that is approved by the US Food and Drug Administration (FDA) to treat cataplexy and excessive daytime sleepiness (EDS) in adult patients and children ≥7 years with…
read more here.
Keywords:
daytime sleepiness;
cataplexy excessive;
sodium;
excessive daytime ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Nature and Science of Sleep"
DOI: 10.2147/nss.s279345
Abstract: Abstract Lower-sodium oxybate (LXB) is an oxybate medication approved to treat cataplexy or excessive daytime sleepiness (EDS) in patients with narcolepsy 7 years of age and older in the United States. LXB was developed as…
read more here.
Keywords:
lower sodium;
sodium;
daytime sleepiness;
lxb ... See more keywords